First City Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

First City Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-750	Closed	-$65.2K	–	304
2016 Q1	$65.2K	Hold	750	–	–	0.04%	250
2015 Q4	$84.6K	Hold	750	–	–	0.06%	213
2015 Q3	$75.8K	Sell	750 -300	-29%	-$36K	0.06%	230
2015 Q2	$129K	Sell	1,050 -75	-7%	-$8.98K	0.09%	178
2015 Q1	$129K	Sell	1,125 -300	-21%	-$33.1K	0.09%	176
2014 Q4	$144K	Sell	1,425 -300	-17%	-$29.2K	0.1%	164
2014 Q3	$157K	Hold	1,725	–	–	0.11%	158
2014 Q2	$148K	Hold	1,725	–	–	0.11%	165
2014 Q1	$136K	Sell	1,725 -1,050	-38%	-$87.5K	0.1%	171
2013 Q4	$210K	Sell	2,775 -219	-7%	-$15.5K	0.17%	139
2013 Q3	$209K	Buy	+2,994	New	+$196K	0.17%	149

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

First City Capital Management's IBB Position: Q2 2016 in Review

First City Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 750 shares — an estimated $65.2K sold.

First City Capital Management first reported a position in IBB in Q3 2013 and held it in 11 quarters. The position peaked at $210K in Q4 2013. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

First City Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
First City Capital Management sold 750 iShares Biotechnology ETF shares in Q2 2016, an estimated $65.2K.
First City Capital Management first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 11 quarters.
First City Capital Management's iShares Biotechnology ETF position peaked at $210K in Q4 2013.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.